ProSciento Prepares to ‘Step Out’ Against Diabetes as a Sponsor for the American Diabetes Association Event in Southern California for a 19th Year
SAN DIEGO, September 16, 2023 – ProSciento, Inc., the leading clinical research organization (CRO) for metabolic diseases, celebrates its 19th year as a corporate sponsor of Step Out: Walk to […]
ProSciento to Present Patient Access & Engagement (PAE) at the NASH Paris Meeting 2023
SAN DIEGO, September 1, 2023 – ProSciento, Inc., the leading clinical research organization (CRO) for metabolic diseases, will present scientific data related to its Patient Access & Engagement (PAE) platform […]
New Liver Disease Nomenclature Announced
June 24, 2023 Announced at the EASL Congress 2023, steatotic liver disease (SLD) is selected as the overarching term for the aetiologies of steatosis. Nonalcoholic fatty liver disease (NAFLD) is […]
ProSciento Appoints David Sockolof as Chief Financial Officer
SAN DIEGO, February 1, 2023 – ProSciento, Inc., a leading specialty clinical research organization (CRO) exclusively focused on metabolic diseases, today announced the appointment of David Sockolof to the role […]
ProSciento Hosts 6th NASH Roundtable Forum in Washington, DC
The 6th NASH Roundtable Forum will facilitate a discussion on serum and imaging-based non-invasive testing, including regulatory considerations, within NAFLD/NASH clinical research.
ProSciento to Present NASH PASS® Registry Data at EASL NAFLD Summit 2022
SAN DIEGO, September 15, 2022 – ProSciento, Inc., a specialty clinical research organization (CRO) focused exclusively on metabolic diseases, will present data related to the NASH PASS (NASH Patient Access […]
ProSciento Prepares to ‘Step Out’ Against Diabetes as the Living Red Sponsor for the American Diabetes Association Fundraising Event in Southern California
SAN DIEGO, September 10, 2022 – ProSciento, Inc., a specialty clinical research organization (CRO) focused exclusively on metabolic diseases, is pleased to announce that it is this year’s Living Red […]
ProSciento Hosts the 5th NASH Roundtable Virtual Forum Focused on Digital Pathology for Histology in NASH Drug Development
June 7, 2022 ‒ ProSciento, Inc. and the NASH Roundtable™ will host the 5th NASH Roundtable Forum on June 16, 2022, as a virtual event. Consisting of leading hepatologists, endocrinologists, […]
ProSciento Appoints Dr. Michelle Mazuranic as Vice President of Medical and Regulatory Affairs
ProSciento, Inc., a specialty clinical research organization (CRO) focused exclusively on diabetes, obesity, non-alcoholic steatohepatitis (NASH), and related metabolic diseases, has announced the appointment of Michelle Mazuranic, PhD, MSM, RD, […]
Key Takeaways from the 4th Annual NASH Roundtable™ Virtual Forum
On November 18, 2021, ProSciento, Inc. co-hosted the 4th Annual NASH Roundtable™ Virtual Forum, a council of leading hepatologists, endocrinologists, and clinical development experts from around the world to discuss advances in the science, clinical research, and therapeutics for nonalcoholic fatty […]